nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ABCG2—hematologic cancer	0.151	0.54	CbGaD
Pitavastatin—ALB—hematologic cancer	0.0658	0.235	CbGaD
Pitavastatin—ABCB1—hematologic cancer	0.0628	0.225	CbGaD
Pitavastatin—ABCG2—Clofarabine—hematologic cancer	0.029	0.0599	CbGbCtD
Pitavastatin—ORM1—Imatinib—hematologic cancer	0.0213	0.0441	CbGbCtD
Pitavastatin—ABCC2—Daunorubicin—hematologic cancer	0.0188	0.0388	CbGbCtD
Pitavastatin—UGT2B7—Epirubicin—hematologic cancer	0.0176	0.0363	CbGbCtD
Pitavastatin—ABCG2—Daunorubicin—hematologic cancer	0.017	0.0351	CbGbCtD
Pitavastatin—ABCG2—Teniposide—hematologic cancer	0.0148	0.0305	CbGbCtD
Pitavastatin—ABCG2—Cladribine—hematologic cancer	0.0142	0.0293	CbGbCtD
Pitavastatin—ABCG2—Imatinib—hematologic cancer	0.013	0.0269	CbGbCtD
Pitavastatin—ABCG2—Nilotinib—hematologic cancer	0.0118	0.0244	CbGbCtD
Pitavastatin—CYP2C9—Bexarotene—hematologic cancer	0.0108	0.0223	CbGbCtD
Pitavastatin—ABCG2—Dasatinib—hematologic cancer	0.0105	0.0216	CbGbCtD
Pitavastatin—ABCB1—Lenalidomide—hematologic cancer	0.0105	0.0216	CbGbCtD
Pitavastatin—ABCG2—Mitoxantrone—hematologic cancer	0.0103	0.0213	CbGbCtD
Pitavastatin—SLCO1B1—Irinotecan—hematologic cancer	0.0102	0.0211	CbGbCtD
Pitavastatin—CYP2C8—Bortezomib—hematologic cancer	0.00947	0.0196	CbGbCtD
Pitavastatin—SLCO1B3—Methotrexate—hematologic cancer	0.0093	0.0192	CbGbCtD
Pitavastatin—ABCC2—Irinotecan—hematologic cancer	0.009	0.0186	CbGbCtD
Pitavastatin—ALB—Imatinib—hematologic cancer	0.00898	0.0185	CbGbCtD
Pitavastatin—CYP2C9—Idarubicin—hematologic cancer	0.00893	0.0184	CbGbCtD
Pitavastatin—ABCG2—Irinotecan—hematologic cancer	0.00813	0.0168	CbGbCtD
Pitavastatin—ABCC2—Vinblastine—hematologic cancer	0.008	0.0165	CbGbCtD
Pitavastatin—ABCC2—Vincristine—hematologic cancer	0.00786	0.0162	CbGbCtD
Pitavastatin—ABCC2—Cisplatin—hematologic cancer	0.00733	0.0151	CbGbCtD
Pitavastatin—CYP2C8—Ifosfamide—hematologic cancer	0.00726	0.015	CbGbCtD
Pitavastatin—ABCC2—Etoposide—hematologic cancer	0.00721	0.0149	CbGbCtD
Pitavastatin—ABCG2—Vincristine—hematologic cancer	0.00711	0.0147	CbGbCtD
Pitavastatin—ABCG2—Cisplatin—hematologic cancer	0.00663	0.0137	CbGbCtD
Pitavastatin—CYP2C9—Bortezomib—hematologic cancer	0.0066	0.0136	CbGbCtD
Pitavastatin—ABCG2—Etoposide—hematologic cancer	0.00652	0.0135	CbGbCtD
Pitavastatin—CYP2C8—Nilotinib—hematologic cancer	0.0063	0.013	CbGbCtD
Pitavastatin—ABCB1—Daunorubicin—hematologic cancer	0.00613	0.0127	CbGbCtD
Pitavastatin—ABCB1—Alitretinoin—hematologic cancer	0.00601	0.0124	CbGbCtD
Pitavastatin—ABCC2—Dexamethasone—hematologic cancer	0.00593	0.0122	CbGbCtD
Pitavastatin—ALB—Prednisone—hematologic cancer	0.00592	0.0122	CbGbCtD
Pitavastatin—CYP2C9—Thalidomide—hematologic cancer	0.00575	0.0119	CbGbCtD
Pitavastatin—ALB—Irinotecan—hematologic cancer	0.00561	0.0116	CbGbCtD
Pitavastatin—CYP2C9—Teniposide—hematologic cancer	0.00549	0.0113	CbGbCtD
Pitavastatin—SLCO1B1—Methotrexate—hematologic cancer	0.00542	0.0112	CbGbCtD
Pitavastatin—ABCG2—Dexamethasone—hematologic cancer	0.00536	0.0111	CbGbCtD
Pitavastatin—CYP2C9—Ifosfamide—hematologic cancer	0.00507	0.0105	CbGbCtD
Pitavastatin—ABCC2—Doxorubicin—hematologic cancer	0.00492	0.0102	CbGbCtD
Pitavastatin—CYP2C9—Imatinib—hematologic cancer	0.00484	0.00999	CbGbCtD
Pitavastatin—ABCC2—Methotrexate—hematologic cancer	0.00476	0.00983	CbGbCtD
Pitavastatin—ABCB1—Imatinib—hematologic cancer	0.0047	0.0097	CbGbCtD
Pitavastatin—ABCG2—Doxorubicin—hematologic cancer	0.00444	0.00918	CbGbCtD
Pitavastatin—CYP2C9—Nilotinib—hematologic cancer	0.0044	0.00908	CbGbCtD
Pitavastatin—ABCG2—Methotrexate—hematologic cancer	0.0043	0.00889	CbGbCtD
Pitavastatin—ABCB1—Nilotinib—hematologic cancer	0.00427	0.00881	CbGbCtD
Pitavastatin—ABCB1—Vinorelbine—hematologic cancer	0.00423	0.00874	CbGbCtD
Pitavastatin—ABCB1—Dasatinib—hematologic cancer	0.00377	0.00779	CbGbCtD
Pitavastatin—ABCB1—Mitoxantrone—hematologic cancer	0.00373	0.00769	CbGbCtD
Pitavastatin—CYP2C8—Etoposide—hematologic cancer	0.00347	0.00717	CbGbCtD
Pitavastatin—ABCB1—Betamethasone—hematologic cancer	0.00332	0.00686	CbGbCtD
Pitavastatin—ABCB1—Gemcitabine—hematologic cancer	0.00329	0.0068	CbGbCtD
Pitavastatin—ABCB1—Prednisolone—hematologic cancer	0.00328	0.00677	CbGbCtD
Pitavastatin—ABCB1—Prednisone—hematologic cancer	0.00309	0.00639	CbGbCtD
Pitavastatin—ALB—Methotrexate—hematologic cancer	0.00297	0.00613	CbGbCtD
Pitavastatin—ABCB1—Irinotecan—hematologic cancer	0.00293	0.00606	CbGbCtD
Pitavastatin—CYP2C8—Dexamethasone—hematologic cancer	0.00285	0.00589	CbGbCtD
Pitavastatin—ABCB1—Vinblastine—hematologic cancer	0.00261	0.00539	CbGbCtD
Pitavastatin—ABCB1—Vincristine—hematologic cancer	0.00256	0.00529	CbGbCtD
Pitavastatin—CYP2C9—Cisplatin—hematologic cancer	0.00246	0.00509	CbGbCtD
Pitavastatin—ABCB1—Cisplatin—hematologic cancer	0.00239	0.00494	CbGbCtD
Pitavastatin—ABCB1—Etoposide—hematologic cancer	0.00235	0.00485	CbGbCtD
Pitavastatin—CYP2C9—Dexamethasone—hematologic cancer	0.00199	0.00411	CbGbCtD
Pitavastatin—ABCB1—Dexamethasone—hematologic cancer	0.00193	0.00399	CbGbCtD
Pitavastatin—ABCB1—Doxorubicin—hematologic cancer	0.0016	0.00331	CbGbCtD
Pitavastatin—ABCB1—Methotrexate—hematologic cancer	0.00155	0.00321	CbGbCtD
Pitavastatin—SLC10A1—gonad—hematologic cancer	0.00118	0.0513	CbGeAlD
Pitavastatin—HMGCR—hematopoietic system—hematologic cancer	0.00107	0.0467	CbGeAlD
Pitavastatin—SLCO1B3—lung—hematologic cancer	0.00103	0.0449	CbGeAlD
Pitavastatin—SLCO1B1—hematopoietic system—hematologic cancer	0.00103	0.0447	CbGeAlD
Pitavastatin—ORM1—hematopoietic system—hematologic cancer	0.000947	0.0413	CbGeAlD
Pitavastatin—SLCO2B1—hematopoietic system—hematologic cancer	0.000907	0.0395	CbGeAlD
Pitavastatin—SLC10A1—testis—hematologic cancer	0.000848	0.037	CbGeAlD
Pitavastatin—Fluvastatin—UGT1A1—hematologic cancer	0.000828	0.325	CrCbGaD
Pitavastatin—HMGCR—gonad—hematologic cancer	0.000814	0.0355	CbGeAlD
Pitavastatin—UGT2B7—testis—hematologic cancer	0.000795	0.0346	CbGeAlD
Pitavastatin—Atorvastatin—UGT1A1—hematologic cancer	0.000722	0.284	CrCbGaD
Pitavastatin—HMGCR—blood—hematologic cancer	0.00071	0.0309	CbGeAlD
Pitavastatin—HMGCR—bone marrow—hematologic cancer	0.000687	0.0299	CbGeAlD
Pitavastatin—SLCO1B1—blood—hematologic cancer	0.00068	0.0296	CbGeAlD
Pitavastatin—ORM1—blood—hematologic cancer	0.000627	0.0273	CbGeAlD
Pitavastatin—HMGCR—lung—hematologic cancer	0.000622	0.0271	CbGeAlD
Pitavastatin—ORM1—bone marrow—hematologic cancer	0.000607	0.0264	CbGeAlD
Pitavastatin—HMGCR—testis—hematologic cancer	0.000587	0.0256	CbGeAlD
Pitavastatin—CYP2C8—hematopoietic system—hematologic cancer	0.000583	0.0254	CbGeAlD
Pitavastatin—Rosuvastatin—ABCG2—hematologic cancer	0.000576	0.226	CrCbGaD
Pitavastatin—ORM1—lung—hematologic cancer	0.00055	0.024	CbGeAlD
Pitavastatin—SLCO2B1—lung—hematologic cancer	0.000527	0.023	CbGeAlD
Pitavastatin—CYP2C9—hematopoietic system—hematologic cancer	0.000518	0.0226	CbGeAlD
Pitavastatin—ABCC2—blood—hematologic cancer	0.000515	0.0225	CbGeAlD
Pitavastatin—SLCO2B1—testis—hematologic cancer	0.000497	0.0217	CbGeAlD
Pitavastatin—ALB—testis—hematologic cancer	0.000455	0.0198	CbGeAlD
Pitavastatin—ABCC2—testis—hematologic cancer	0.000426	0.0186	CbGeAlD
Pitavastatin—HMGCR—lymph node—hematologic cancer	0.000425	0.0185	CbGeAlD
Pitavastatin—CYP2C8—blood—hematologic cancer	0.000387	0.0168	CbGeAlD
Pitavastatin—ORM1—lymph node—hematologic cancer	0.000376	0.0164	CbGeAlD
Pitavastatin—ABCG2—blood—hematologic cancer	0.000376	0.0164	CbGeAlD
Pitavastatin—ABCG2—bone marrow—hematologic cancer	0.000364	0.0158	CbGeAlD
Pitavastatin—SLCO2B1—lymph node—hematologic cancer	0.00036	0.0157	CbGeAlD
Pitavastatin—CYP2C9—blood—hematologic cancer	0.000343	0.015	CbGeAlD
Pitavastatin—ALB—lymph node—hematologic cancer	0.00033	0.0144	CbGeAlD
Pitavastatin—ABCG2—lung—hematologic cancer	0.000329	0.0144	CbGeAlD
Pitavastatin—CYP2C8—testis—hematologic cancer	0.00032	0.0139	CbGeAlD
Pitavastatin—ABCG2—testis—hematologic cancer	0.000311	0.0135	CbGeAlD
Pitavastatin—ABCC2—lymph node—hematologic cancer	0.000309	0.0135	CbGeAlD
Pitavastatin—ABCB1—hematopoietic system—hematologic cancer	0.00028	0.0122	CbGeAlD
Pitavastatin—Rosuvastatin—ALB—hematologic cancer	0.000251	0.0986	CrCbGaD
Pitavastatin—ABCG2—lymph node—hematologic cancer	0.000225	0.00982	CbGeAlD
Pitavastatin—ABCB1—gonad—hematologic cancer	0.000213	0.00927	CbGeAlD
Pitavastatin—ABCB1—blood—hematologic cancer	0.000185	0.00808	CbGeAlD
Pitavastatin—ABCB1—bone marrow—hematologic cancer	0.000179	0.00781	CbGeAlD
Pitavastatin—Atorvastatin—ABCB1—hematologic cancer	0.000169	0.0663	CrCbGaD
Pitavastatin—ABCB1—lung—hematologic cancer	0.000162	0.00708	CbGeAlD
Pitavastatin—ABCB1—testis—hematologic cancer	0.000153	0.00668	CbGeAlD
Pitavastatin—ABCB1—lymph node—hematologic cancer	0.000111	0.00484	CbGeAlD
Pitavastatin—Malaise—Betamethasone—hematologic cancer	6.44e-05	0.000471	CcSEcCtD
Pitavastatin—Malaise—Dexamethasone—hematologic cancer	6.44e-05	0.000471	CcSEcCtD
Pitavastatin—Asthenia—Ifosfamide—hematologic cancer	6.44e-05	0.000471	CcSEcCtD
Pitavastatin—Pruritus—Alitretinoin—hematologic cancer	6.42e-05	0.00047	CcSEcCtD
Pitavastatin—Feeling abnormal—Cisplatin—hematologic cancer	6.37e-05	0.000466	CcSEcCtD
Pitavastatin—Pruritus—Ifosfamide—hematologic cancer	6.35e-05	0.000464	CcSEcCtD
Pitavastatin—Insomnia—Prednisolone—hematologic cancer	6.32e-05	0.000463	CcSEcCtD
Pitavastatin—Dizziness—Thalidomide—hematologic cancer	6.31e-05	0.000462	CcSEcCtD
Pitavastatin—Nausea—Bortezomib—hematologic cancer	6.28e-05	0.00046	CcSEcCtD
Pitavastatin—Hypersensitivity—Mitoxantrone—hematologic cancer	6.28e-05	0.000459	CcSEcCtD
Pitavastatin—Hypersensitivity—Irinotecan—hematologic cancer	6.28e-05	0.000459	CcSEcCtD
Pitavastatin—Asthenia—Vincristine—hematologic cancer	6.28e-05	0.000459	CcSEcCtD
Pitavastatin—Diarrhoea—Carmustine—hematologic cancer	6.27e-05	0.000459	CcSEcCtD
Pitavastatin—Nausea—Bleomycin—hematologic cancer	6.24e-05	0.000456	CcSEcCtD
Pitavastatin—Rash—Thiotepa—hematologic cancer	6.22e-05	0.000455	CcSEcCtD
Pitavastatin—Dermatitis—Thiotepa—hematologic cancer	6.21e-05	0.000455	CcSEcCtD
Pitavastatin—Diarrhoea—Alitretinoin—hematologic cancer	6.21e-05	0.000454	CcSEcCtD
Pitavastatin—Headache—Thiotepa—hematologic cancer	6.18e-05	0.000452	CcSEcCtD
Pitavastatin—Diarrhoea—Ifosfamide—hematologic cancer	6.14e-05	0.000449	CcSEcCtD
Pitavastatin—Nausea—Vinorelbine—hematologic cancer	6.14e-05	0.000449	CcSEcCtD
Pitavastatin—Asthenia—Irinotecan—hematologic cancer	6.11e-05	0.000447	CcSEcCtD
Pitavastatin—Asthenia—Mitoxantrone—hematologic cancer	6.11e-05	0.000447	CcSEcCtD
Pitavastatin—Fatigue—Etoposide—hematologic cancer	6.11e-05	0.000447	CcSEcCtD
Pitavastatin—Myalgia—Betamethasone—hematologic cancer	6.08e-05	0.000445	CcSEcCtD
Pitavastatin—Myalgia—Dexamethasone—hematologic cancer	6.08e-05	0.000445	CcSEcCtD
Pitavastatin—Jaundice—Epirubicin—hematologic cancer	6.07e-05	0.000444	CcSEcCtD
Pitavastatin—Dizziness—Carmustine—hematologic cancer	6.06e-05	0.000443	CcSEcCtD
Pitavastatin—Constipation—Etoposide—hematologic cancer	6.06e-05	0.000443	CcSEcCtD
Pitavastatin—Rash—Thalidomide—hematologic cancer	6.02e-05	0.00044	CcSEcCtD
Pitavastatin—Discomfort—Dexamethasone—hematologic cancer	6.01e-05	0.00044	CcSEcCtD
Pitavastatin—Discomfort—Betamethasone—hematologic cancer	6.01e-05	0.00044	CcSEcCtD
Pitavastatin—Dermatitis—Thalidomide—hematologic cancer	6.01e-05	0.00044	CcSEcCtD
Pitavastatin—Dizziness—Alitretinoin—hematologic cancer	6e-05	0.000439	CcSEcCtD
Pitavastatin—Diarrhoea—Vincristine—hematologic cancer	5.99e-05	0.000438	CcSEcCtD
Pitavastatin—Headache—Thalidomide—hematologic cancer	5.98e-05	0.000437	CcSEcCtD
Pitavastatin—Hepatitis—Methotrexate—hematologic cancer	5.97e-05	0.000437	CcSEcCtD
Pitavastatin—Asthenia—Gemcitabine—hematologic cancer	5.95e-05	0.000436	CcSEcCtD
Pitavastatin—Dizziness—Ifosfamide—hematologic cancer	5.93e-05	0.000434	CcSEcCtD
Pitavastatin—Pruritus—Gemcitabine—hematologic cancer	5.87e-05	0.00043	CcSEcCtD
Pitavastatin—Nausea—Thiotepa—hematologic cancer	5.86e-05	0.000429	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	5.86e-05	0.000428	CcSEcCtD
Pitavastatin—Feeling abnormal—Etoposide—hematologic cancer	5.84e-05	0.000427	CcSEcCtD
Pitavastatin—Diarrhoea—Mitoxantrone—hematologic cancer	5.83e-05	0.000426	CcSEcCtD
Pitavastatin—Diarrhoea—Irinotecan—hematologic cancer	5.83e-05	0.000426	CcSEcCtD
Pitavastatin—Insomnia—Triamcinolone—hematologic cancer	5.81e-05	0.000425	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Etoposide—hematologic cancer	5.79e-05	0.000424	CcSEcCtD
Pitavastatin—Dizziness—Vincristine—hematologic cancer	5.78e-05	0.000423	CcSEcCtD
Pitavastatin—Rash—Carmustine—hematologic cancer	5.78e-05	0.000423	CcSEcCtD
Pitavastatin—Ill-defined disorder—Prednisone—hematologic cancer	5.77e-05	0.000422	CcSEcCtD
Pitavastatin—Dermatitis—Carmustine—hematologic cancer	5.77e-05	0.000422	CcSEcCtD
Pitavastatin—Feeling abnormal—Prednisolone—hematologic cancer	5.76e-05	0.000421	CcSEcCtD
Pitavastatin—Headache—Carmustine—hematologic cancer	5.74e-05	0.00042	CcSEcCtD
Pitavastatin—Rash—Alitretinoin—hematologic cancer	5.72e-05	0.000419	CcSEcCtD
Pitavastatin—Dermatitis—Alitretinoin—hematologic cancer	5.72e-05	0.000418	CcSEcCtD
Pitavastatin—Hypersensitivity—Cisplatin—hematologic cancer	5.7e-05	0.000417	CcSEcCtD
Pitavastatin—Headache—Alitretinoin—hematologic cancer	5.69e-05	0.000416	CcSEcCtD
Pitavastatin—Diarrhoea—Gemcitabine—hematologic cancer	5.68e-05	0.000415	CcSEcCtD
Pitavastatin—Nausea—Thalidomide—hematologic cancer	5.67e-05	0.000415	CcSEcCtD
Pitavastatin—Dyspepsia—Triamcinolone—hematologic cancer	5.66e-05	0.000414	CcSEcCtD
Pitavastatin—Rash—Ifosfamide—hematologic cancer	5.66e-05	0.000414	CcSEcCtD
Pitavastatin—Dermatitis—Ifosfamide—hematologic cancer	5.65e-05	0.000414	CcSEcCtD
Pitavastatin—Dizziness—Irinotecan—hematologic cancer	5.63e-05	0.000412	CcSEcCtD
Pitavastatin—Urticaria—Etoposide—hematologic cancer	5.63e-05	0.000412	CcSEcCtD
Pitavastatin—Jaundice—Doxorubicin—hematologic cancer	5.62e-05	0.000411	CcSEcCtD
Pitavastatin—Malaise—Prednisone—hematologic cancer	5.61e-05	0.000411	CcSEcCtD
Pitavastatin—Abdominal pain—Etoposide—hematologic cancer	5.6e-05	0.00041	CcSEcCtD
Pitavastatin—Hepatitis—Epirubicin—hematologic cancer	5.59e-05	0.000409	CcSEcCtD
Pitavastatin—Hypoaesthesia—Epirubicin—hematologic cancer	5.56e-05	0.000407	CcSEcCtD
Pitavastatin—Urticaria—Prednisolone—hematologic cancer	5.55e-05	0.000406	CcSEcCtD
Pitavastatin—Asthenia—Cisplatin—hematologic cancer	5.55e-05	0.000406	CcSEcCtD
Pitavastatin—Fatigue—Triamcinolone—hematologic cancer	5.54e-05	0.000405	CcSEcCtD
Pitavastatin—Rash—Vincristine—hematologic cancer	5.52e-05	0.000404	CcSEcCtD
Pitavastatin—Dermatitis—Vincristine—hematologic cancer	5.51e-05	0.000403	CcSEcCtD
Pitavastatin—Headache—Vincristine—hematologic cancer	5.48e-05	0.000401	CcSEcCtD
Pitavastatin—Nausea—Carmustine—hematologic cancer	5.44e-05	0.000398	CcSEcCtD
Pitavastatin—Nausea—Alitretinoin—hematologic cancer	5.39e-05	0.000395	CcSEcCtD
Pitavastatin—Rash—Mitoxantrone—hematologic cancer	5.37e-05	0.000393	CcSEcCtD
Pitavastatin—Rash—Irinotecan—hematologic cancer	5.37e-05	0.000393	CcSEcCtD
Pitavastatin—Dermatitis—Mitoxantrone—hematologic cancer	5.37e-05	0.000393	CcSEcCtD
Pitavastatin—Dermatitis—Irinotecan—hematologic cancer	5.37e-05	0.000393	CcSEcCtD
Pitavastatin—Headache—Irinotecan—hematologic cancer	5.34e-05	0.00039	CcSEcCtD
Pitavastatin—Headache—Mitoxantrone—hematologic cancer	5.34e-05	0.00039	CcSEcCtD
Pitavastatin—Nausea—Ifosfamide—hematologic cancer	5.33e-05	0.00039	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5.31e-05	0.000389	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	5.31e-05	0.000389	CcSEcCtD
Pitavastatin—Arthralgia—Prednisone—hematologic cancer	5.3e-05	0.000388	CcSEcCtD
Pitavastatin—Myalgia—Prednisone—hematologic cancer	5.3e-05	0.000388	CcSEcCtD
Pitavastatin—Feeling abnormal—Triamcinolone—hematologic cancer	5.3e-05	0.000388	CcSEcCtD
Pitavastatin—Diarrhoea—Cisplatin—hematologic cancer	5.29e-05	0.000387	CcSEcCtD
Pitavastatin—Insomnia—Betamethasone—hematologic cancer	5.27e-05	0.000386	CcSEcCtD
Pitavastatin—Insomnia—Dexamethasone—hematologic cancer	5.27e-05	0.000386	CcSEcCtD
Pitavastatin—Discomfort—Prednisone—hematologic cancer	5.23e-05	0.000383	CcSEcCtD
Pitavastatin—Rash—Gemcitabine—hematologic cancer	5.23e-05	0.000383	CcSEcCtD
Pitavastatin—Dermatitis—Gemcitabine—hematologic cancer	5.23e-05	0.000382	CcSEcCtD
Pitavastatin—Hypersensitivity—Etoposide—hematologic cancer	5.22e-05	0.000382	CcSEcCtD
Pitavastatin—Headache—Gemcitabine—hematologic cancer	5.2e-05	0.00038	CcSEcCtD
Pitavastatin—Nausea—Vincristine—hematologic cancer	5.2e-05	0.00038	CcSEcCtD
Pitavastatin—Hepatitis—Doxorubicin—hematologic cancer	5.17e-05	0.000379	CcSEcCtD
Pitavastatin—Hypersensitivity—Prednisolone—hematologic cancer	5.15e-05	0.000377	CcSEcCtD
Pitavastatin—Hypoaesthesia—Doxorubicin—hematologic cancer	5.15e-05	0.000377	CcSEcCtD
Pitavastatin—Dyspepsia—Betamethasone—hematologic cancer	5.13e-05	0.000376	CcSEcCtD
Pitavastatin—Dyspepsia—Dexamethasone—hematologic cancer	5.13e-05	0.000376	CcSEcCtD
Pitavastatin—Urticaria—Triamcinolone—hematologic cancer	5.11e-05	0.000374	CcSEcCtD
Pitavastatin—Asthenia—Etoposide—hematologic cancer	5.08e-05	0.000372	CcSEcCtD
Pitavastatin—Nausea—Mitoxantrone—hematologic cancer	5.06e-05	0.00037	CcSEcCtD
Pitavastatin—Nausea—Irinotecan—hematologic cancer	5.06e-05	0.00037	CcSEcCtD
Pitavastatin—Back pain—Methotrexate—hematologic cancer	5.03e-05	0.000368	CcSEcCtD
Pitavastatin—Fatigue—Betamethasone—hematologic cancer	5.03e-05	0.000368	CcSEcCtD
Pitavastatin—Fatigue—Dexamethasone—hematologic cancer	5.03e-05	0.000368	CcSEcCtD
Pitavastatin—Pruritus—Etoposide—hematologic cancer	5.01e-05	0.000367	CcSEcCtD
Pitavastatin—Nausea—Gemcitabine—hematologic cancer	4.93e-05	0.000361	CcSEcCtD
Pitavastatin—Rash—Cisplatin—hematologic cancer	4.88e-05	0.000357	CcSEcCtD
Pitavastatin—Dermatitis—Cisplatin—hematologic cancer	4.87e-05	0.000356	CcSEcCtD
Pitavastatin—Diarrhoea—Etoposide—hematologic cancer	4.85e-05	0.000355	CcSEcCtD
Pitavastatin—Ill-defined disorder—Methotrexate—hematologic cancer	4.83e-05	0.000353	CcSEcCtD
Pitavastatin—Feeling abnormal—Dexamethasone—hematologic cancer	4.81e-05	0.000352	CcSEcCtD
Pitavastatin—Feeling abnormal—Betamethasone—hematologic cancer	4.81e-05	0.000352	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.77e-05	0.000349	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Betamethasone—hematologic cancer	4.77e-05	0.000349	CcSEcCtD
Pitavastatin—Hypersensitivity—Triamcinolone—hematologic cancer	4.74e-05	0.000346	CcSEcCtD
Pitavastatin—Back pain—Epirubicin—hematologic cancer	4.71e-05	0.000344	CcSEcCtD
Pitavastatin—Malaise—Methotrexate—hematologic cancer	4.69e-05	0.000343	CcSEcCtD
Pitavastatin—Dizziness—Etoposide—hematologic cancer	4.69e-05	0.000343	CcSEcCtD
Pitavastatin—Muscle spasms—Epirubicin—hematologic cancer	4.68e-05	0.000342	CcSEcCtD
Pitavastatin—Urticaria—Dexamethasone—hematologic cancer	4.63e-05	0.000339	CcSEcCtD
Pitavastatin—Urticaria—Betamethasone—hematologic cancer	4.63e-05	0.000339	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.63e-05	0.000339	CcSEcCtD
Pitavastatin—Dizziness—Prednisolone—hematologic cancer	4.62e-05	0.000338	CcSEcCtD
Pitavastatin—Asthenia—Triamcinolone—hematologic cancer	4.61e-05	0.000337	CcSEcCtD
Pitavastatin—Abdominal pain—Dexamethasone—hematologic cancer	4.61e-05	0.000337	CcSEcCtD
Pitavastatin—Abdominal pain—Betamethasone—hematologic cancer	4.61e-05	0.000337	CcSEcCtD
Pitavastatin—Nausea—Cisplatin—hematologic cancer	4.59e-05	0.000336	CcSEcCtD
Pitavastatin—Insomnia—Prednisone—hematologic cancer	4.59e-05	0.000336	CcSEcCtD
Pitavastatin—Pruritus—Triamcinolone—hematologic cancer	4.55e-05	0.000333	CcSEcCtD
Pitavastatin—Ill-defined disorder—Epirubicin—hematologic cancer	4.52e-05	0.00033	CcSEcCtD
Pitavastatin—Dyspepsia—Prednisone—hematologic cancer	4.47e-05	0.000327	CcSEcCtD
Pitavastatin—Rash—Etoposide—hematologic cancer	4.47e-05	0.000327	CcSEcCtD
Pitavastatin—Dermatitis—Etoposide—hematologic cancer	4.46e-05	0.000327	CcSEcCtD
Pitavastatin—Headache—Etoposide—hematologic cancer	4.44e-05	0.000325	CcSEcCtD
Pitavastatin—Arthralgia—Methotrexate—hematologic cancer	4.43e-05	0.000324	CcSEcCtD
Pitavastatin—Myalgia—Methotrexate—hematologic cancer	4.43e-05	0.000324	CcSEcCtD
Pitavastatin—Rash—Prednisolone—hematologic cancer	4.41e-05	0.000322	CcSEcCtD
Pitavastatin—Dermatitis—Prednisolone—hematologic cancer	4.4e-05	0.000322	CcSEcCtD
Pitavastatin—Malaise—Epirubicin—hematologic cancer	4.39e-05	0.000321	CcSEcCtD
Pitavastatin—Fatigue—Prednisone—hematologic cancer	4.38e-05	0.00032	CcSEcCtD
Pitavastatin—Headache—Prednisolone—hematologic cancer	4.38e-05	0.00032	CcSEcCtD
Pitavastatin—Discomfort—Methotrexate—hematologic cancer	4.37e-05	0.00032	CcSEcCtD
Pitavastatin—Back pain—Doxorubicin—hematologic cancer	4.36e-05	0.000319	CcSEcCtD
Pitavastatin—Constipation—Prednisone—hematologic cancer	4.34e-05	0.000318	CcSEcCtD
Pitavastatin—Muscle spasms—Doxorubicin—hematologic cancer	4.33e-05	0.000317	CcSEcCtD
Pitavastatin—Confusional state—Methotrexate—hematologic cancer	4.28e-05	0.000313	CcSEcCtD
Pitavastatin—Dizziness—Triamcinolone—hematologic cancer	4.25e-05	0.000311	CcSEcCtD
Pitavastatin—Nausea—Etoposide—hematologic cancer	4.21e-05	0.000308	CcSEcCtD
Pitavastatin—Feeling abnormal—Prednisone—hematologic cancer	4.19e-05	0.000306	CcSEcCtD
Pitavastatin—Asthenia—Dexamethasone—hematologic cancer	4.18e-05	0.000306	CcSEcCtD
Pitavastatin—Asthenia—Betamethasone—hematologic cancer	4.18e-05	0.000306	CcSEcCtD
Pitavastatin—Ill-defined disorder—Doxorubicin—hematologic cancer	4.18e-05	0.000306	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Prednisone—hematologic cancer	4.15e-05	0.000304	CcSEcCtD
Pitavastatin—Nausea—Prednisolone—hematologic cancer	4.15e-05	0.000304	CcSEcCtD
Pitavastatin—Arthralgia—Epirubicin—hematologic cancer	4.14e-05	0.000303	CcSEcCtD
Pitavastatin—Myalgia—Epirubicin—hematologic cancer	4.14e-05	0.000303	CcSEcCtD
Pitavastatin—Pruritus—Betamethasone—hematologic cancer	4.13e-05	0.000302	CcSEcCtD
Pitavastatin—Pruritus—Dexamethasone—hematologic cancer	4.13e-05	0.000302	CcSEcCtD
Pitavastatin—Discomfort—Epirubicin—hematologic cancer	4.09e-05	0.0003	CcSEcCtD
Pitavastatin—Malaise—Doxorubicin—hematologic cancer	4.06e-05	0.000297	CcSEcCtD
Pitavastatin—Rash—Triamcinolone—hematologic cancer	4.05e-05	0.000297	CcSEcCtD
Pitavastatin—Dermatitis—Triamcinolone—hematologic cancer	4.05e-05	0.000296	CcSEcCtD
Pitavastatin—Urticaria—Prednisone—hematologic cancer	4.03e-05	0.000295	CcSEcCtD
Pitavastatin—Headache—Triamcinolone—hematologic cancer	4.03e-05	0.000295	CcSEcCtD
Pitavastatin—Abdominal pain—Prednisone—hematologic cancer	4.01e-05	0.000294	CcSEcCtD
Pitavastatin—Confusional state—Epirubicin—hematologic cancer	4.01e-05	0.000293	CcSEcCtD
Pitavastatin—Diarrhoea—Dexamethasone—hematologic cancer	3.99e-05	0.000292	CcSEcCtD
Pitavastatin—Diarrhoea—Betamethasone—hematologic cancer	3.99e-05	0.000292	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.87e-05	0.000283	CcSEcCtD
Pitavastatin—Dizziness—Dexamethasone—hematologic cancer	3.86e-05	0.000282	CcSEcCtD
Pitavastatin—Dizziness—Betamethasone—hematologic cancer	3.86e-05	0.000282	CcSEcCtD
Pitavastatin—Insomnia—Methotrexate—hematologic cancer	3.84e-05	0.000281	CcSEcCtD
Pitavastatin—Arthralgia—Doxorubicin—hematologic cancer	3.83e-05	0.000281	CcSEcCtD
Pitavastatin—Myalgia—Doxorubicin—hematologic cancer	3.83e-05	0.000281	CcSEcCtD
Pitavastatin—Nausea—Triamcinolone—hematologic cancer	3.82e-05	0.000279	CcSEcCtD
Pitavastatin—Discomfort—Doxorubicin—hematologic cancer	3.79e-05	0.000277	CcSEcCtD
Pitavastatin—Hypersensitivity—Prednisone—hematologic cancer	3.74e-05	0.000274	CcSEcCtD
Pitavastatin—Dyspepsia—Methotrexate—hematologic cancer	3.74e-05	0.000273	CcSEcCtD
Pitavastatin—Confusional state—Doxorubicin—hematologic cancer	3.71e-05	0.000271	CcSEcCtD
Pitavastatin—Rash—Betamethasone—hematologic cancer	3.68e-05	0.000269	CcSEcCtD
Pitavastatin—Rash—Dexamethasone—hematologic cancer	3.68e-05	0.000269	CcSEcCtD
Pitavastatin—Dermatitis—Betamethasone—hematologic cancer	3.67e-05	0.000269	CcSEcCtD
Pitavastatin—Dermatitis—Dexamethasone—hematologic cancer	3.67e-05	0.000269	CcSEcCtD
Pitavastatin—Fatigue—Methotrexate—hematologic cancer	3.66e-05	0.000268	CcSEcCtD
Pitavastatin—Headache—Dexamethasone—hematologic cancer	3.65e-05	0.000267	CcSEcCtD
Pitavastatin—Headache—Betamethasone—hematologic cancer	3.65e-05	0.000267	CcSEcCtD
Pitavastatin—Asthenia—Prednisone—hematologic cancer	3.64e-05	0.000267	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.62e-05	0.000265	CcSEcCtD
Pitavastatin—Pruritus—Prednisone—hematologic cancer	3.59e-05	0.000263	CcSEcCtD
Pitavastatin—Insomnia—Epirubicin—hematologic cancer	3.59e-05	0.000263	CcSEcCtD
Pitavastatin—Feeling abnormal—Methotrexate—hematologic cancer	3.5e-05	0.000256	CcSEcCtD
Pitavastatin—Dyspepsia—Epirubicin—hematologic cancer	3.5e-05	0.000256	CcSEcCtD
Pitavastatin—Diarrhoea—Prednisone—hematologic cancer	3.47e-05	0.000254	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Methotrexate—hematologic cancer	3.47e-05	0.000254	CcSEcCtD
Pitavastatin—Nausea—Betamethasone—hematologic cancer	3.46e-05	0.000253	CcSEcCtD
Pitavastatin—Nausea—Dexamethasone—hematologic cancer	3.46e-05	0.000253	CcSEcCtD
Pitavastatin—Fatigue—Epirubicin—hematologic cancer	3.42e-05	0.000251	CcSEcCtD
Pitavastatin—Constipation—Epirubicin—hematologic cancer	3.4e-05	0.000249	CcSEcCtD
Pitavastatin—Urticaria—Methotrexate—hematologic cancer	3.37e-05	0.000247	CcSEcCtD
Pitavastatin—Dizziness—Prednisone—hematologic cancer	3.36e-05	0.000246	CcSEcCtD
Pitavastatin—Abdominal pain—Methotrexate—hematologic cancer	3.36e-05	0.000245	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.35e-05	0.000245	CcSEcCtD
Pitavastatin—Insomnia—Doxorubicin—hematologic cancer	3.32e-05	0.000243	CcSEcCtD
Pitavastatin—Feeling abnormal—Epirubicin—hematologic cancer	3.27e-05	0.000239	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Epirubicin—hematologic cancer	3.25e-05	0.000238	CcSEcCtD
Pitavastatin—Dyspepsia—Doxorubicin—hematologic cancer	3.24e-05	0.000237	CcSEcCtD
Pitavastatin—Rash—Prednisone—hematologic cancer	3.2e-05	0.000234	CcSEcCtD
Pitavastatin—Dermatitis—Prednisone—hematologic cancer	3.2e-05	0.000234	CcSEcCtD
Pitavastatin—Headache—Prednisone—hematologic cancer	3.18e-05	0.000233	CcSEcCtD
Pitavastatin—Fatigue—Doxorubicin—hematologic cancer	3.17e-05	0.000232	CcSEcCtD
Pitavastatin—Urticaria—Epirubicin—hematologic cancer	3.16e-05	0.000231	CcSEcCtD
Pitavastatin—Constipation—Doxorubicin—hematologic cancer	3.14e-05	0.00023	CcSEcCtD
Pitavastatin—Abdominal pain—Epirubicin—hematologic cancer	3.14e-05	0.00023	CcSEcCtD
Pitavastatin—Hypersensitivity—Methotrexate—hematologic cancer	3.13e-05	0.000229	CcSEcCtD
Pitavastatin—Asthenia—Methotrexate—hematologic cancer	3.05e-05	0.000223	CcSEcCtD
Pitavastatin—Feeling abnormal—Doxorubicin—hematologic cancer	3.03e-05	0.000222	CcSEcCtD
Pitavastatin—Nausea—Prednisone—hematologic cancer	3.02e-05	0.000221	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.01e-05	0.00022	CcSEcCtD
Pitavastatin—Pruritus—Methotrexate—hematologic cancer	3e-05	0.00022	CcSEcCtD
Pitavastatin—Hypersensitivity—Epirubicin—hematologic cancer	2.93e-05	0.000214	CcSEcCtD
Pitavastatin—Urticaria—Doxorubicin—hematologic cancer	2.92e-05	0.000214	CcSEcCtD
Pitavastatin—Abdominal pain—Doxorubicin—hematologic cancer	2.91e-05	0.000213	CcSEcCtD
Pitavastatin—Diarrhoea—Methotrexate—hematologic cancer	2.9e-05	0.000212	CcSEcCtD
Pitavastatin—Asthenia—Epirubicin—hematologic cancer	2.85e-05	0.000209	CcSEcCtD
Pitavastatin—Pruritus—Epirubicin—hematologic cancer	2.81e-05	0.000206	CcSEcCtD
Pitavastatin—Dizziness—Methotrexate—hematologic cancer	2.81e-05	0.000205	CcSEcCtD
Pitavastatin—Diarrhoea—Epirubicin—hematologic cancer	2.72e-05	0.000199	CcSEcCtD
Pitavastatin—Hypersensitivity—Doxorubicin—hematologic cancer	2.71e-05	0.000198	CcSEcCtD
Pitavastatin—Rash—Methotrexate—hematologic cancer	2.68e-05	0.000196	CcSEcCtD
Pitavastatin—Dermatitis—Methotrexate—hematologic cancer	2.67e-05	0.000196	CcSEcCtD
Pitavastatin—Headache—Methotrexate—hematologic cancer	2.66e-05	0.000195	CcSEcCtD
Pitavastatin—Asthenia—Doxorubicin—hematologic cancer	2.64e-05	0.000193	CcSEcCtD
Pitavastatin—Dizziness—Epirubicin—hematologic cancer	2.63e-05	0.000192	CcSEcCtD
Pitavastatin—Pruritus—Doxorubicin—hematologic cancer	2.6e-05	0.00019	CcSEcCtD
Pitavastatin—Nausea—Methotrexate—hematologic cancer	2.52e-05	0.000184	CcSEcCtD
Pitavastatin—Diarrhoea—Doxorubicin—hematologic cancer	2.51e-05	0.000184	CcSEcCtD
Pitavastatin—Rash—Epirubicin—hematologic cancer	2.5e-05	0.000183	CcSEcCtD
Pitavastatin—Dermatitis—Epirubicin—hematologic cancer	2.5e-05	0.000183	CcSEcCtD
Pitavastatin—Headache—Epirubicin—hematologic cancer	2.49e-05	0.000182	CcSEcCtD
Pitavastatin—Dizziness—Doxorubicin—hematologic cancer	2.43e-05	0.000178	CcSEcCtD
Pitavastatin—Nausea—Epirubicin—hematologic cancer	2.36e-05	0.000173	CcSEcCtD
Pitavastatin—Rash—Doxorubicin—hematologic cancer	2.32e-05	0.00017	CcSEcCtD
Pitavastatin—Dermatitis—Doxorubicin—hematologic cancer	2.32e-05	0.000169	CcSEcCtD
Pitavastatin—Headache—Doxorubicin—hematologic cancer	2.3e-05	0.000168	CcSEcCtD
Pitavastatin—Nausea—Doxorubicin—hematologic cancer	2.18e-05	0.00016	CcSEcCtD
Pitavastatin—CYP2C8—Metabolism—ALOX5—hematologic cancer	4.86e-06	6.57e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ALOX5—hematologic cancer	4.83e-06	6.53e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CD—hematologic cancer	4.83e-06	6.53e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ABCB1—hematologic cancer	4.83e-06	6.52e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PTPN11—hematologic cancer	4.82e-06	6.51e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—IDH1—hematologic cancer	4.81e-06	6.49e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CREBBP—hematologic cancer	4.8e-06	6.49e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	4.8e-06	6.49e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CA9—hematologic cancer	4.78e-06	6.45e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ACP5—hematologic cancer	4.78e-06	6.45e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ALB—hematologic cancer	4.77e-06	6.45e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	4.76e-06	6.44e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—TXN—hematologic cancer	4.75e-06	6.42e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ABCC3—hematologic cancer	4.75e-06	6.42e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTO1—hematologic cancer	4.75e-06	6.42e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTP1—hematologic cancer	4.72e-06	6.38e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NCOR2—hematologic cancer	4.71e-06	6.37e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NUP98—hematologic cancer	4.71e-06	6.36e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—NCOR1—hematologic cancer	4.69e-06	6.33e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTM1—hematologic cancer	4.69e-06	6.33e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NUP98—hematologic cancer	4.68e-06	6.32e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CG—hematologic cancer	4.68e-06	6.32e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SPHK1—hematologic cancer	4.65e-06	6.28e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ADCY7—hematologic cancer	4.57e-06	6.17e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NCOA3—hematologic cancer	4.57e-06	6.17e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3R1—hematologic cancer	4.56e-06	6.17e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CD—hematologic cancer	4.55e-06	6.15e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—CREBBP—hematologic cancer	4.55e-06	6.14e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ADCY7—hematologic cancer	4.54e-06	6.14e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NCOA3—hematologic cancer	4.54e-06	6.14e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NUP214—hematologic cancer	4.54e-06	6.13e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NUP214—hematologic cancer	4.51e-06	6.1e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ALB—hematologic cancer	4.5e-06	6.07e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.49e-06	6.07e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—IDH1—hematologic cancer	4.49e-06	6.06e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ABCB1—hematologic cancer	4.47e-06	6.04e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—UGT1A1—hematologic cancer	4.47e-06	6.04e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.47e-06	6.03e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTEN—hematologic cancer	4.47e-06	6.03e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—MTR—hematologic cancer	4.45e-06	6.01e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ABCG2—hematologic cancer	4.45e-06	6.01e-05	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	4.45e-06	6.01e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCC3—hematologic cancer	4.44e-06	6e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTO1—hematologic cancer	4.44e-06	6e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—TXN—hematologic cancer	4.44e-06	6e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ABCG2—hematologic cancer	4.42e-06	5.97e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—MTR—hematologic cancer	4.42e-06	5.97e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.38e-06	5.91e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ENO2—hematologic cancer	4.36e-06	5.89e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.35e-06	5.87e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CRABP1—hematologic cancer	4.35e-06	5.87e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SPHK1—hematologic cancer	4.34e-06	5.87e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTM1—hematologic cancer	4.34e-06	5.86e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—NCOR1—hematologic cancer	4.34e-06	5.86e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ENO2—hematologic cancer	4.34e-06	5.86e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CREBBP—hematologic cancer	4.33e-06	5.86e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CD—hematologic cancer	4.31e-06	5.83e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3R1—hematologic cancer	4.3e-06	5.81e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—EP300—hematologic cancer	4.26e-06	5.75e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALOX5—hematologic cancer	4.24e-06	5.72e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.23e-06	5.72e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTT1—hematologic cancer	4.23e-06	5.71e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CB—hematologic cancer	4.21e-06	5.69e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTT1—hematologic cancer	4.21e-06	5.68e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—UGT1A1—hematologic cancer	4.17e-06	5.64e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.16e-06	5.63e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—MTHFR—hematologic cancer	4.14e-06	5.6e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.14e-06	5.59e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SDC1—hematologic cancer	4.13e-06	5.58e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SDC1—hematologic cancer	4.11e-06	5.55e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CD—hematologic cancer	4.11e-06	5.55e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NUP98—hematologic cancer	4.1e-06	5.54e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3R1—hematologic cancer	4.07e-06	5.5e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC22A1—hematologic cancer	4.06e-06	5.48e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CRABP1—hematologic cancer	4.06e-06	5.48e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ALB—hematologic cancer	4.06e-06	5.48e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ADCY7—hematologic cancer	3.98e-06	5.38e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NCOA3—hematologic cancer	3.98e-06	5.38e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CB—hematologic cancer	3.97e-06	5.36e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—JAK2—hematologic cancer	3.96e-06	5.35e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALOX5—hematologic cancer	3.96e-06	5.34e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NUP214—hematologic cancer	3.95e-06	5.34e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.95e-06	5.33e-05	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.94e-06	5.32e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.93e-06	5.3e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.9e-06	5.27e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3R1—hematologic cancer	3.88e-06	5.24e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—MTR—hematologic cancer	3.87e-06	5.23e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ABCG2—hematologic cancer	3.87e-06	5.23e-05	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PIK3CA—hematologic cancer	3.86e-06	5.22e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—MTHFR—hematologic cancer	3.84e-06	5.18e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NUP98—hematologic cancer	3.83e-06	5.18e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ENO2—hematologic cancer	3.8e-06	5.13e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CB—hematologic cancer	3.76e-06	5.08e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.73e-06	5.04e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ADCY7—hematologic cancer	3.72e-06	5.03e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NCOA3—hematologic cancer	3.72e-06	5.03e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.71e-06	5.01e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NUP214—hematologic cancer	3.69e-06	4.99e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTT1—hematologic cancer	3.68e-06	4.98e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.66e-06	4.94e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.65e-06	4.93e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTEN—hematologic cancer	3.64e-06	4.92e-05	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	3.63e-06	4.91e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCG2—hematologic cancer	3.62e-06	4.89e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—MTR—hematologic cancer	3.62e-06	4.89e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SDC1—hematologic cancer	3.6e-06	4.86e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CB—hematologic cancer	3.58e-06	4.84e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.58e-06	4.83e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ENO2—hematologic cancer	3.55e-06	4.79e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CD44—hematologic cancer	3.51e-06	4.75e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NQO1—hematologic cancer	3.51e-06	4.75e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NQO1—hematologic cancer	3.49e-06	4.72e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CD44—hematologic cancer	3.49e-06	4.72e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	3.48e-06	4.7e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—EP300—hematologic cancer	3.47e-06	4.69e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IL2—hematologic cancer	3.45e-06	4.66e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.45e-06	4.66e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.44e-06	4.65e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.44e-06	4.65e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTEN—hematologic cancer	3.43e-06	4.63e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.42e-06	4.62e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.39e-06	4.58e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SDC1—hematologic cancer	3.36e-06	4.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYCS—hematologic cancer	3.33e-06	4.49e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYCS—hematologic cancer	3.31e-06	4.47e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	3.3e-06	4.46e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—HSP90AA1—hematologic cancer	3.29e-06	4.44e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—EP300—hematologic cancer	3.27e-06	4.42e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.23e-06	4.36e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CREBBP—hematologic cancer	3.23e-06	4.36e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CG—hematologic cancer	3.22e-06	4.35e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.21e-06	4.34e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.17e-06	4.29e-05	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AKT1—hematologic cancer	3.16e-06	4.26e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CA—hematologic cancer	3.15e-06	4.26e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—EP300—hematologic cancer	3.1e-06	4.18e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTEN—hematologic cancer	3.1e-06	4.18e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CD44—hematologic cancer	3.06e-06	4.14e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NQO1—hematologic cancer	3.06e-06	4.14e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	3.06e-06	4.13e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.03e-06	4.1e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ALB—hematologic cancer	3.02e-06	4.08e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SRC—hematologic cancer	3.01e-06	4.07e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CREBBP—hematologic cancer	2.99e-06	4.04e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.97e-06	4.02e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.96e-06	3.99e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—EP300—hematologic cancer	2.95e-06	3.99e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—hematologic cancer	2.93e-06	3.96e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTP1—hematologic cancer	2.93e-06	3.96e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTP1—hematologic cancer	2.91e-06	3.94e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NRAS—hematologic cancer	2.9e-06	3.91e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYCS—hematologic cancer	2.9e-06	3.91e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	2.89e-06	3.9e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.88e-06	3.89e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CD44—hematologic cancer	2.86e-06	3.86e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NQO1—hematologic cancer	2.86e-06	3.86e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.84e-06	3.83e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CD—hematologic cancer	2.83e-06	3.83e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.82e-06	3.81e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.8e-06	3.78e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ALB—hematologic cancer	2.8e-06	3.78e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MAPK3—hematologic cancer	2.78e-06	3.75e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ABCB1—hematologic cancer	2.78e-06	3.75e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ABCB1—hematologic cancer	2.76e-06	3.73e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYCS—hematologic cancer	2.71e-06	3.66e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTM1—hematologic cancer	2.69e-06	3.64e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NCOR1—hematologic cancer	2.69e-06	3.64e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TGFB1—hematologic cancer	2.69e-06	3.64e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.69e-06	3.63e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTM1—hematologic cancer	2.68e-06	3.62e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NCOR1—hematologic cancer	2.68e-06	3.62e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3R1—hematologic cancer	2.68e-06	3.61e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	2.67e-06	3.6e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AKT1—hematologic cancer	2.57e-06	3.48e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CA—hematologic cancer	2.57e-06	3.47e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTP1—hematologic cancer	2.55e-06	3.45e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—KRAS—hematologic cancer	2.49e-06	3.37e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CB—hematologic cancer	2.47e-06	3.34e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.42e-06	3.27e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	2.42e-06	3.27e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.39e-06	3.22e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.38e-06	3.22e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—MTHFR—hematologic cancer	2.37e-06	3.2e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NCOR1—hematologic cancer	2.35e-06	3.17e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTM1—hematologic cancer	2.35e-06	3.17e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.31e-06	3.12e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTEN—hematologic cancer	2.3e-06	3.11e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CA—hematologic cancer	2.29e-06	3.1e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.26e-06	3.05e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—hematologic cancer	2.22e-06	2.99e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—EP300—hematologic cancer	2.2e-06	2.97e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.19e-06	2.96e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.19e-06	2.96e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CA—hematologic cancer	2.18e-06	2.95e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTEN—hematologic cancer	2.13e-06	2.88e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—HRAS—hematologic cancer	2.12e-06	2.86e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.1e-06	2.83e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AKT1—hematologic cancer	2.1e-06	2.83e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.09e-06	2.82e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—MTHFR—hematologic cancer	2.07e-06	2.8e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—EP300—hematologic cancer	2.04e-06	2.75e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2e-06	2.7e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CG—hematologic cancer	1.99e-06	2.69e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AKT1—hematologic cancer	1.98e-06	2.67e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.94e-06	2.62e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—AKT1—hematologic cancer	1.87e-06	2.53e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.85e-06	2.51e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CREBBP—hematologic cancer	1.84e-06	2.49e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKT1—hematologic cancer	1.78e-06	2.41e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.76e-06	2.38e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CD—hematologic cancer	1.75e-06	2.36e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.74e-06	2.35e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALB—hematologic cancer	1.74e-06	2.35e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.71e-06	2.31e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.66e-06	2.24e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3R1—hematologic cancer	1.65e-06	2.23e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.63e-06	2.2e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	1.63e-06	2.2e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CREBBP—hematologic cancer	1.62e-06	2.18e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.53e-06	2.07e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.53e-06	2.07e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CB—hematologic cancer	1.52e-06	2.06e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALB—hematologic cancer	1.51e-06	2.04e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.51e-06	2.04e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CA—hematologic cancer	1.51e-06	2.03e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.45e-06	1.95e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.43e-06	1.93e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALB—hematologic cancer	1.41e-06	1.91e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.35e-06	1.83e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.34e-06	1.8e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.33e-06	1.79e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTEN—hematologic cancer	1.32e-06	1.79e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTEN—hematologic cancer	1.32e-06	1.78e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—EP300—hematologic cancer	1.26e-06	1.71e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—EP300—hematologic cancer	1.26e-06	1.7e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.25e-06	1.69e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKT1—hematologic cancer	1.23e-06	1.66e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTEN—hematologic cancer	1.15e-06	1.56e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—EP300—hematologic cancer	1.1e-06	1.49e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTEN—hematologic cancer	1.08e-06	1.46e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—EP300—hematologic cancer	1.03e-06	1.39e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CA—hematologic cancer	9.34e-07	1.26e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CA—hematologic cancer	9.29e-07	1.26e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CA—hematologic cancer	8.14e-07	1.1e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKT1—hematologic cancer	7.63e-07	1.03e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CA—hematologic cancer	7.6e-07	1.03e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKT1—hematologic cancer	7.59e-07	1.03e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKT1—hematologic cancer	6.65e-07	8.98e-06	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKT1—hematologic cancer	6.21e-07	8.39e-06	CbGpPWpGaD
